secwatch.observer — SEC 8-K summary
======================================

Issuer:     STRATA Skin Sciences, Inc. (SSKN)
CIK:        0001051514
Form:       8-K
Filed at:   2023-05-15T23:59:59+00:00
Accession:  0001140361-23-024714
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

STRATA Skin Sciences Q1 revenue up 8.6% to $7.6M; net loss widens to $2.8M
--------------------------------------------------------------------------

- Revenue of $7.6M vs $7.0M YoY; global recurring revenue $5.2M, equipment revenue $2.4M.
- Net loss of $2.8M ($0.08 loss per share) vs net loss of $2.5M ($0.07 per share) YoY.
- Launched TheraClear X in Jan 2023; placed 44 devices in Q1, total 58 U.S. placements.
- Sold over 3,000 TheraClear treatments in Q1; signed India distribution deal with Spectra Medical.
- Full-year 2023 revenue guidance reaffirmed at $38M–$40M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1051514/000114036123024714/0001140361-23-024714-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1051514/000114036123024714/brhc20052965_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-024714

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer